Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
08 Oct 2019 |
SH01 |
Statement of capital following an allotment of shares on 3 October 2019
|
|
|
27 Aug 2019 |
AA |
Full accounts made up to 31 December 2018
|
|
|
29 Jul 2019 |
CS01 |
Confirmation statement made on 25 July 2019 with updates
|
|
|
03 May 2019 |
AP01 |
Appointment of David John Chiswell as a director on 24 April 2019
|
|
|
20 Dec 2018 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
06 Dec 2018 |
AP01 |
Appointment of Alek Safarian as a director on 21 November 2018
|
|
|
06 Dec 2018 |
TM01 |
Termination of appointment of Kyparissia Katie Sirinakis as a director on 21 November 2018
|
|
|
03 Dec 2018 |
SH01 |
Statement of capital following an allotment of shares on 29 November 2018
|
|
|
23 Nov 2018 |
SH01 |
Statement of capital following an allotment of shares on 22 November 2018
|
|
|
02 Oct 2018 |
PSC07 |
Cessation of Epidarex Capital Partners Limited as a person with significant control on 26 June 2017
|
|
|
01 Oct 2018 |
PSC07 |
Cessation of James Frederick Spicer as a person with significant control on 31 March 2017
|
|
|
01 Oct 2018 |
PSC07 |
Cessation of Vivienne Frances Cox as a person with significant control on 31 March 2017
|
|
|
01 Oct 2018 |
PSC07 |
Cessation of Sophia Karagiannis as a person with significant control on 31 March 2017
|
|
|
24 Sep 2018 |
RP04PSC02 |
Second filing for the notification of Epidarex Capital Partners Limited as a person with significant control
|
|
|
24 Sep 2018 |
RP04PSC02 |
Second filing for the notification of Epidarex Capital Ii, Lp as a person with significant control
|
|
|
27 Jul 2018 |
CS01 |
Confirmation statement made on 25 July 2018 with no updates
|
|
|
21 Jun 2018 |
RP04AP01 |
Second filing for the appointment of Dr Tim Craig Wilson as a director
|
|
|
11 Jun 2018 |
AA |
Full accounts made up to 31 December 2017
|
|
|
30 May 2018 |
PSC02 |
Notification of Epidarex Capital Ii Lp as a person with significant control on 29 May 2018
-
ANNOTATION
Clarification a second filed PSC02 was registered on 24/09/2018.
|
|
|
30 May 2018 |
PSC02 |
Notification of Epidarex Capital Partners Limited as a person with significant control on 29 May 2018
-
ANNOTATION
Clarification a second filed PSC02 was registered on 03/09/2018
-
ANNOTATION
Clarification a second filed PSC02 was registered on 24/09/2018.
|
|
|
30 May 2018 |
PSC04 |
Change of details for Dr Sophia Karagiannis as a person with significant control on 29 May 2018
|
|
|
30 May 2018 |
PSC04 |
Change of details for Dr James Frederick Spicer as a person with significant control on 29 May 2018
|
|
|
29 May 2018 |
CH01 |
Director's details changed for Dr Vivienne Frances Cox on 3 May 2018
|
|
|
29 May 2018 |
PSC04 |
Change of details for Vivienne Frances Cox as a person with significant control on 3 May 2018
|
|
|
03 May 2018 |
AD01 |
Registered office address changed from 119 the Hub 300 Kensal Road London W10 5BE England to London Bioscience Innovation Centre 2 Royal College Street London NW1 0NH on 3 May 2018
|
|